Autolus Therapeutics (AUTL) Inventory (2024 - 2026)

Autolus Therapeutics' (AUTL) quarterly Inventory came in at $33.2 million in Q4 2025, up 702.54% YoY from $4.1 million in Q4 2024, and up 19.79% on a QoQ basis from $27.7 million in Q3 2025.

Autolus Therapeutics (AUTL) Inventory (2024 - 2026) Analysis & Trends

Autolus Therapeutics (AUTL) has 2 years of Inventory data on file, last reported at $33.2 million in Q4 2025.

  • Quarterly Inventory rose 702.54% year-over-year to $33.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $33.2 million (up 702.54% YoY) and the FY2025 annual result came in at $33.2 million, up 702.54% from the prior year.
  • Inventory rose to $33.2 million in Q4 2025, from $27.7 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $33.2 million in Q4 2025 to a low of $4.1 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 1.77 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 3.08 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 371.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 732.60 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 358,916.96
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 97.11 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 142.38 Mn
10 Autolus Therapeutics 763.37 Mn 561.74 Mn 25.22 Mn 33.43 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 33.43 Mn
Dec 31, 2025 33.21 Mn
Sep 30, 2025 27.72 Mn
Jun 30, 2025 23.94 Mn
Mar 31, 2025 14.65 Mn
Dec 31, 2024 4.14 Mn